Post Quarterly Financial Result Conference call with investors / analyst

Board & Shareholder Meetings View source PDF

TORNTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-4.4%1-day move

₹4518.00

prior close

₹4374.90

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.1+0.2+0.3—-4.4-2.5-3.0-2.5-1.5-1.0-3.3+1.3+9.5—

Up moveDown movePending

AI summary

Torrent Pharmaceuticals has scheduled a post-earnings investor teleconference for 22nd May 2026 at 06:30 PM IST to discuss its financial performance for the quarter and year ended 31st March 2026 (Q4/FY26 results). The company has filed this intimation to both BSE and NSE as per listing obligations. The conference call will cover quarterly and annual performance, with dial-in details and international toll-free numbers provided for analyst participation. The filing was made by Company Secretary Chintan M. Trivedi on 12th May 2026.

Likely market impact

This is a routine post-results investor engagement. The conference call gives investors and analysts an opportunity to seek clarification on the Q4 and full-year FY26 financial performance. No new material information is being disclosed in this filing.